Evidence map›Paper›PMID 35603841›Full record

ArticleJNCI cancer spectrum2022

Prediagnosis Leisure-Time Physical Activity and Lung Cancer Survival: A Pooled Analysis of 11 Cohorts.

Jae Jeong Yang, Danxia Yu, Emily White, Dong Hoon Lee, William Blot, Kim Robien, Rashmi Sinha, Yikyung Park, Yumie Takata, Yu-Tang Gao and 19 more

Registry-linked trialAbstract read
In one paragraph

Article in JNCI cancer spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06406660 (Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06406660 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

TypeinterventionalSponsorHenan Cancer HospitalRan2024 to 2026Enrolled20ConditionsSmall Cell Lung CancerArmsChemotherapy and targeted-therapy guided by organoid drug sensitivity test
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Telemedicine-based inspiratory muscle training and walking promotion with lung cancer survivors following curative intent therapy: a parallel-group pilot randomized trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Jae Jeong YangVanderbilt Epidemiology Center, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-6370-2243
Danxia YuVanderbilt Epidemiology Center, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-1710-9382
Emily WhiteCancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Dong Hoon LeeDepartments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
William BlotVanderbilt Epidemiology Center, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Kim RobienDepartment of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.ORCID 0000-0002-2120-2280
Rashmi SinhaDivision of Epidemiology & Genetics, National Cancer Institute, Bethesda, MD, USA.
Yikyung ParkDivision of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-6281-489X
Yumie TakataProgram of Nutrition, School of Biological and Population Health, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.
Yu-Tang GaoDepartment of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Karl Smith-ByrneGenetic Epidemiology Group, International Agency for Research on Cancer, Lyons, France.ORCID 0000-0002-1932-7463
Evelyn M MonninkhofJulius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, the Netherlands.
Rudolf KaaksDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Arnulf LanghammerHUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway.
Kristin Benjaminsen BorchDepartment of Community Medicine, UiT-the Arctic University of Norway, Tromsø, Norway.
Laila Al-ShaarDepartments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-2774-3464
Qing LanDivision of Epidemiology & Genetics, National Cancer Institute, Bethesda, MD, USA.
Elin Pettersen SørgjerdDepartment of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway.
Xuehong ZhangChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Clair ZhuDivision of Epidemiology & Genetics, National Cancer Institute, Bethesda, MD, USA.
María Dolores ChirlaqueDepartment of Epidemiology, Murcia Regional Health Council IMIBArrixaca, Ronda de Levante, Murcia, Spain.
Gianluca SeveriUniversity Paris-Saclay, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" Team, CESP UMR1018, Villejuif, France.ORCID 0000-0001-7157-419X
Kim OvervadDepartment of Public Health, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-6429-7921
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.ORCID 0000-0002-8008-5096
Dagfinn AuneDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.ORCID 0000-0002-4533-1722
Mattias JohanssonGenetic Epidemiology Group, International Agency for Research on Cancer, Lyons, France.ORCID 0000-0002-3116-5081
Stephanie A Smith-WarnerDepartments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-3462-8608
Wei ZhengVanderbilt Epidemiology Center, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Xiao-Ou ShuVanderbilt Epidemiology Center, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-0711-8314

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Prospective Studies of Diet and Cancer in the AARP CohortZIACP010196 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SINHA, RASHMI · 2009 to 2025
$21.0M
Cancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0M
EPIDEMIOLOGY OF CANCER IN A COHORT OF OLDER WOMENR01CA039742 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LAZOVICH, DEANN · 1985 to 2014
$8.0M
Calcium intake and lung cancer: effect modification by sex and smoking statusR03CA183021 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHU, XIAO-OU · 2014 to 2015
$157k
NCI NIH HHS P01 CA087969NCI NIH HHS R01 CA039742NCI NIH HHS R03 CA183021NCI NIH HHS U01 CA167552NCI NIH HHS UM1 CA186107NIH HHS R03 CA183021World Health Organization 001
6 · The paper itself

Abstract

backgroundLittle is known about the association between physical activity before cancer diagnosis and survival among lung cancer patients. In this pooled analysis of 11 prospective cohorts, we investigated associations of prediagnosis leisure-time physical activity (LTPA) with all-cause and lung cancer-specific mortality among incident lung cancer patients.

methodsUsing self-reported data on regular engagement in exercise and sports activities collected at study enrollment, we assessed metabolic equivalent hours (MET-h) of prediagnosis LTPA per week. According to the Physical Activity Guidelines for Americans, prediagnosis LTPA was classified into inactivity, less than 8.3 and at least 8.3 MET-h per week (the minimum recommended range). Cox regression was used to estimate hazard ratios (HRs) and 95% confidence interval (CIs) for all-cause and lung cancer-specific mortality after adjustment for major prognostic factors and lifetime smoking history.

resultsOf 20 494 incident lung cancer patients, 16 864 died, including 13 596 deaths from lung cancer (overall 5-year relative survival rate = 20.9%, 95% CI = 20.3% to 21.5%). Compared with inactivity, prediagnosis LTPA of more than 8.3 MET-h per week was associated with a lower hazard of all-cause mortality (multivariable-adjusted HR = 0.93, 95% CI = 0.88 to 0.99), but not with lung cancer-specific mortality (multivariable-adjusted HR = 0.99, 95% CI = 0.95 to 1.04), among the overall population. Additive interaction was found by tumor stage (Pinteraction = .008 for all-cause mortality and .003 for lung cancer-specific mortality). When restricted to localized cancer, prediagnosis LTPA of at least 8.3 MET-h per week linked to 20% lower mortality: multivariable-adjusted HRs were 0.80 (95% CI = 0.67 to 0.97) for all-cause mortality and 0.80 (95% CI = 0.65 to 0.99) for lung cancer-specific mortality.

conclusionsRegular participation in LTPA that met or exceeded the minimum Physical Activity Guidelines was associated with reduced hazards of mortality among lung cancer patients, especially those with early stage cancer.

Indexed as

Leisure ActivitiesLung NeoplasmsExerciseHumansMotor ActivityProspective StudiesUnited States

Identifiers

PMID35603841
PMCPMC8962711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.